TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05980234

Intervention type: DEVICE
Intervention: Total Hip Arthroplasty with Longevity IT Oblique Liners
Description: Primary or Revision Total Hip Arthroplasty using the Longevity IT Oblique liners according to the approved indications and compatible device.

Intervention type: DEVICE
Intervention: Total Hip Arthroplasty with Longevity IT Offset Liners
Description: Primary or Revision Total Hip Arthroplasty using the Longevity IT Offset liners according to the approved indications and compatible device.
Study: NCT06553248

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GZR4
Description: Administered once weekly subcutaneously (s.c., under the skin) for 6 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Degludec
Description: Administered once daily subcutaneously (s.c., under the skin) for 6 weeks
Study: NCT05217589

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Funny/Amusing Video Clips
Description: Participants watch 5-7 minutes of video clips that are funny/amusing in nature

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Horror/Scary Video Clips
Description: Participants watch 5-7 minutes of video clips that are scary in nature

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thrilling/Suspenseful Video Clips
Description: Participants watch 5-7 minutes of video clips that are thrilling/suspenseful in nature
Study: NCT06552962

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Whole body vibration
Description: The aim of this study is to reveal the effect of exercises performed with WBV on the myofascial tissue of the lumbar region and the tone of superficial back muscles, as well as to investigate the effects on pain, function, muscle strength, balance, proprioception and endurance parameters, compared to the exercise-only group.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: lumbar stabilization exercises
Description: The control group will undergo lumbar stabilization exercises twice a week for 6 weeks.
Study: NCT06073158

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Esophageal biopsy collection during anastomosis
Description: During the anastomosis, the surgeon will collect an esophageal mucosa biopsy
Study: NCT06357169

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Venus Glow
Description: two treatments over a one week period. At the first visit they will complete an initial questionnaire regarding current scalp care practices, skin type, and hair type. An initial baseline scalp swab and HairMetrix photography in the two swab sites will be taken at the beginning of this visit. Treatment with the Venus Glow™ device will also occur. To treat, the scalp will be divided into four quadrants. Swab samples will be collected at the first baseline and concurrent treatment session, second treatment session and 3-6 days after the last treatment when participants have returned to their usual cleansing routine.
Study: NCT06687343

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: EAA Supplement
Description: Dissolved in water and ingested 4 times a day

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: EAA Supplement
Description: Dissolved in water and ingested 4 times a day

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: EAA Supplement
Description: Dissolved in water and ingested 4 times a day

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: NEAA Supplement
Description: Dissolved in water and ingested 4 times a day

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Maltodextrin Supplement
Description: Dissolved in water and ingested 4 times a day
Study: NCT06692543

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active population
Description: 1 blood withdraw, questionnaire and tests

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inactive population
Description: 1 blood withdraw, questionnaire and tests
Study: NCT06693583

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Headsets
Description: Virtual reality (VR) headsets are used as a form of distraction technique widely throughout healthcare. Women will be assisted to apply the VR prior to their colposcopy examination beginning. They will be shown an immersive video of walking through a forest that reminds them to breath deeply. The aim is that this will relax them during the colposcopy examination.
Study: NCT06743360

Intervention type: DEVICE
Intervention: Insertion
Description: Twenty orthodontic mini-implants (n=20) (AbsoAnchor SH 1312-08, Dentos, Daegu, South Korea) were randomly chosen (every third screw from a sample of 60) numbered consecutively, and embedded in polivynyl siloxane impression material Variotype heavy putty (Kulzer, Hanau, Germany).

Intervention type: DEVICE
Intervention: Scanning
Description: After the planned movement is achieved, the mini-implant will be removed and provided to laboratory analysis. All screws were sputtered (0.6µm CaCO₄) and scanned in blue-light technology, using a 3D optical scanner (Atos III, Triple Scan, GOM, Germany) to the nearest 2 micrometres. Due to regularly performed calibration procedures, recommended by the manufacturer, an error study was superfluous. Subsequently, the scans were superimposed using GOM Inspect Software (GOM, Braunschweig, Germany) in order to verify the shape and size repeatability.
Study: NCT06742957

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tapinarof Cream 1%
Description: Cream

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: VTAMA®
Description: Cream
Study: NCT06254651

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High resuscitation table
Description: Participants will be invited to administer face-mask ventilation setting the table height to the operator's xiphoid process in a neonatal manikin.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low resuscitation table
Description: Participants will be invited to administer face-mask ventilation setting the table height to the operator's superior anterior iliac spines in a neonatal manikin.
Study: NCT06742957

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Cream
Study: NCT06746402

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986278
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986278
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986278
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986278
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986278
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Specified dose on specified days
Study: NCT06746857

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: repetitive transcranial magnetic stimulation
Description: Bilateral dorsolateral prefrontal cortex Intermitten Theta Burst Stimulation to
Study: NCT06747637

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Skill-building classes
Description: Unidos en el Cuidado is a manualized, multi-family group intervention provided at no cost vis-à-vis videoconferencing or on-site by trained facilitators Sessions are held weekly for 1.5 hours. Class components include caregiver role identity; skills-building; knowledge attainment; attitudinal changes; resource-sharing; practice/role-plays; homework; videos, handouts. Classes will be provided online with some classes offered in the community, if available

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wait list control group
Description: The intervention is the same; the wait period is longer to receive the intervention described in Group A.
Study: NCT06746753

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Description: randomized to receive Angiotensin II continuous infusion for up to 48 hours

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norepinephrine
Description: randomized to receive Norepinephrine continuous infusion for up to 48 hours
Study: NCT05378178

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10381
Description: Each subject will receive a single dose(C0) of HS-10381 and then repeat doses(C1, C2...) for 21-day cycles. Participants may continue on study drug until disease progression, unacceptable toxicity, or other withdrawal criteria is met.
Study: NCT05889091

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HRQOL instruments
Description: These instruments include Face Q for Appearance, Eating \& drinking, Swallowing, and Saliva (patient-reported); the Neck Dissection Impairment Index (patient-reported); the Long-term ENT-Subjective/Objective/Management/Analysis (LENT-SOMA) for skin-subcutaneous tissue, muscle-soft tissue, mucosa - oral and pharyngeal, salivary gland, and mandible (patient- and clinician-reported); modified barium swallow study (8-point penetration aspiration scale).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LENT SOMA instrument
Description: LENT SOMA instrument will also be provided to summarize objective quality-of-life-related measures recorded at 12 months postoperatively, including interincisor distance (mm); neck range of motion measured in degrees of flexion, extension, lateral flexion, and rotation to both sides; and shoulder range of motion, measured in degrees of abduction.
Study: NCT06479148

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: enVista® Aspire™
Description: Eyes will receive enVista® Aspire™ lenses

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: An IOL with a slightly extended depth of focus
Description: Eyes will receive lenses with a slightly extended depth of focus

Intervention type: DEVICE
Group type: OTHER
Intervention: MX60E
Description: Eyes will receive MX60E lenses
Study: NCT05726864

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ELI-002 7P
Description: ELI-002 Amph-CpG-7909 admixed with ELI-002 Amph-Peptides 7P administered via SC injection weekly for 4 consecutive weeks, followed by bi-weekly injections over 4 weeks, during the Immunization Period; additional SC injections weekly for 4 weeks during the Booster Period (the two periods are separated by 2 months of no dosing)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ELI-002 7P
Description: ELI-002 Amph-CpG-7909 admixed with ELI-002 Amph-Peptides 7P administered via SC injection weekly for 4 consecutive weeks, followed by bi-weekly injections over 4 weeks, during the Immunization Period; additional SC injections weekly for 4 weeks during the Booster Period (the two periods are separated by 2 months of no dosing)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ELI-002 7P
Description: ELI-002 Amph-CpG-7909 admixed with ELI-002 Amph-Peptides 7P administered via SC injection weekly for 4 consecutive weeks, followed by bi-weekly injections over 4 weeks, during the Immunization Period; additional SC injections weekly for 4 weeks during the Booster Period (the two periods are separated by 2 months of no dosing)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ELI-002 7P
Description: ELI-002 Amph-CpG-7909 admixed with ELI-002 Amph-Peptides 7P administered via SC injection weekly for 4 consecutive weeks, followed by bi-weekly injections over 4 weeks, during the Immunization Period; additional SC injections weekly for 4 weeks during the Booster Period (the two periods are separated by 2 months of no dosing)
Study: NCT04972201

Intervention type: DEVICE
Intervention: Multi-cancer early detection test
Description: Blood collection and multi-cancer early detection test

Intervention type: DEVICE
Intervention: Multi-cancer early detection test
Description: Blood collection and multi-cancer early detection test
Study: NCT06482983

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical Ventilation Mode
Description: after intubation different ventilation mode (VC,PC,PC-VG)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical Ventilation Mode
Description: after intubation different ventilation mode (VC,PC,PC-VG)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical Ventilation Mode
Description: after intubation different ventilation mode (VC,PC,PC-VG)
Study: NCT05432609

Intervention type: DIAGNOSTIC_TEST
Intervention: Weight bearing CT
Description: Weight bearing CT in loaded and unloaded positions

Intervention type: DIAGNOSTIC_TEST
Intervention: Weight bearing CT
Description: Weight bearing CT in loaded and unloaded positions
Study: NCT06379100

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial magnetic stimulation
Description: Intermittent Theta-Burst Transcranial Magnetic Stimulation

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial magnetic stimulation
Description: Intermittent Theta-Burst Transcranial Magnetic Stimulation
Study: NCT04549454

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FITSTART+ PBI
Description: Personalized normative feedback on other parents behaviors + alcohol-specific parenting advice + general parenting advice

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: General Parenting Advice
Description: General parenting advice
Study: NCT06461507

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Janda's Approach
Description: For Tightened Structures Stretching applied toIliopsoas and Erector spinal muscles (5 repetitions of stretching with 30-s hold for each muscle). For Strengthening of Weakened Structures; Glute bridge and Abdominal crunch(10 repetitions of each).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Janda's Approach
Description: For Tightened Structures Stretching applied toIliopsoas and Erector spinal muscles (5 repetitions of stretching with 30-s hold for each muscle). For Strengthening of Weakened Structures; Glute bridge and Abdominal crunch(10 repetitions of each).
Study: NCT06320743

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NIRS ,Ventilation parameters
Description: NIRS ,Ventilation parameters :~Until the patient is taken to the operating table and leaves the operating table routine monitoring parameters, BIS values ,cerebral and peripheral NIRS values, until the patient is intubated and extubated ventilation parameters These parameters; 0. min (before induction), 1. min after induction, pre-post intubation, 5. min, 10. min, 20. min, 30. min, 45. min, 60. min, 90. min after connecting to the ventilator. It will then be noted at 1 hour intervals, and finally at the 5th minute after extubation.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NIRS ,Ventilation parameters
Description: NIRS ,Ventilation parameters :~Until the patient is taken to the operating table and leaves the operating table routine monitoring parameters, BIS values ,cerebral and peripheral NIRS values, until the patient is intubated and extubated ventilation parameters These parameters; 0. min (before induction), 1. min after induction, pre-post intubation, 5. min, 10. min, 20. min, 30. min, 45. min, 60. min, 90. min after connecting to the ventilator. It will then be noted at 1 hour intervals, and finally at the 5th minute after extubation.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen concentration
Description: Oxygen concentration :~Alarm limits appropriate to the patient's weight will be determined for all patients, the lower limit of inspired O2 will be set as 30%, the upper limit of inspired CO2 will be set as 5mmHg. If the inspired O2 value drops below 30%, the pulse oximeter peripheral SpO2 drops below 97, and the NIRS values drop by 20%, the oxygen concentration will be increased by 10%
Study: NCT05452668

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser Therapy
Description: - Laser will be applied with the specified wave length using a diode laser device over 4 consecutive days.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser Therapy
Description: - Laser will be applied with the specified wave length using a diode laser device over 4 consecutive days.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham procedure
Description: Seventeen patients will receive mock treatment which is the exact repetition of the treatment modality but without any laser emission plus the current Protocol(antifungal +/- antiviral and analgesics) used by CCHE which will be recorded in the patient's file
Study: NCT03699865

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nicotine content
Description: Study-supplied cigarettes will contain either intermediate or very low nicotine content

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nicotine content
Description: Study-supplied cigarettes will contain either intermediate or very low nicotine content

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nicotine content
Description: Study-supplied cigarettes will contain either intermediate or very low nicotine content
Study: NCT05840380

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: instrumental soft tissue mobilization
Description: Individual supine for application will be deposited. The Graston instrument glides over the tissues of the individual. cream will be applied to make it easier, then the physiotherapist will will stand on its side at the level and graston for 5 minutes. superficially on the thoracolumbal fascia between the sacrum and T12. will be applied

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: instrumental soft tissue mobilization
Description: Individual supine for application will be deposited. The Graston instrument glides over the tissues of the individual. cream will be applied to make it easier, then the physiotherapist will will stand on its side at the level and graston for 5 minutes. superficially on the thoracolumbal fascia between the sacrum and T12. will be applied
Study: NCT04617171

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benralizumab 30 MG/ML [Fasenra]
Description: Benralizumab/placebo initiated at an acute severe asthma exacerbation, then continued over a period of 48 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Benralizumab/placebo initiated at an acute severe asthma exacerbation, then continued over a period of 48 weeks
Study: NCT06042504

Intervention type: OTHER
Intervention: Survey
Description: Subjects will complete a survey. The survey consists of two parts, A and B. During part A subjects will indicate which of the 5 cohorts they identify as. Successively in part B, subject will complete a survey known as the Perceived Stress Scale (PSS).

Intervention type: OTHER
Intervention: Survey
Description: Subjects will complete a survey. The survey consists of two parts, A and B. During part A subjects will indicate which of the 5 cohorts they identify as. Successively in part B, subject will complete a survey known as the Perceived Stress Scale (PSS).

Intervention type: OTHER
Intervention: Survey
Description: Subjects will complete a survey. The survey consists of two parts, A and B. During part A subjects will indicate which of the 5 cohorts they identify as. Successively in part B, subject will complete a survey known as the Perceived Stress Scale (PSS).

Intervention type: OTHER
Intervention: Survey
Description: Subjects will complete a survey. The survey consists of two parts, A and B. During part A subjects will indicate which of the 5 cohorts they identify as. Successively in part B, subject will complete a survey known as the Perceived Stress Scale (PSS).

Intervention type: OTHER
Intervention: Survey
Description: Subjects will complete a survey. The survey consists of two parts, A and B. During part A subjects will indicate which of the 5 cohorts they identify as. Successively in part B, subject will complete a survey known as the Perceived Stress Scale (PSS).
Study: NCT05509114

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Glasses
Description: The intervention group of patients watched a video with virtual reality glasses during the transrectal biopsy process.
Study: NCT05510440

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alpha-amino acid derivatives
Description: Alpha-amino acid derivatives mainly citrulline will be used as a supplement to reduce kidneys and other internal organs damage

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Alpha-amino acid derivatives
Description: Alpha-amino acid derivatives mainly citrulline will be used as a supplement to reduce kidneys and other internal organs damage
Study: NCT05469191

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group 5 STS
Description: For 8 weeks, 3 times per week and 3 sets of 5 repetitions during the first month, then 5 sets of 5 repetitions during the second month.~Between each repetition, there will be a rest of 30 to 60 seconds approximately.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group 10 STS
Description: For 8 weeks, 3 times per week and 3 sets of 10 repetitions during the first month, then 5 sets of 10 repetitions during the second month.~Between each repetition, there will be a rest of 30 to 60 seconds approximately.
Study: NCT06224257

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linperlisib
Description: Elevated PI3K activity in T-LGL likely plays an important role in the ability of the pathologic cells to avoid homeostatic apoptosis, since inhibition of this pathway leads to apoptosis in the population of cells harboring the pathologic clone. More importantly, the activity of this pathway may represent a kind of Achilles heel for T-LGL in that PI3K inhibitors alone are quite effective at inducing spontaneous apoptosis in the clonal CTLs after a short incubation.
Study: NCT06191640

Intervention type: DRUG
Intervention: Ivacaftor or elexacaftor/tezacaftor/ivacaftor
Description: HEMT's are prescribed at the discretion of the treating physician and is not dictated by the principal investigator of this study.
Study: NCT04941560

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT04910945

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VENUS AIME (RoboCor)
Description: VENUS AIME is a micro-coring device of the skin that can potentially help to reduce visible skin scarring, improve skin laxity and reduce wrinkles.